These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 32305626)
1. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends. Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395 [TBL] [Abstract][Full Text] [Related]
3. Effect of Korean Red Ginseng on metabolic syndrome. Yoon SJ; Kim SK; Lee NY; Choi YR; Kim HS; Gupta H; Youn GS; Sung H; Shin MJ; Suk KT J Ginseng Res; 2021 May; 45(3):380-389. PubMed ID: 34025131 [TBL] [Abstract][Full Text] [Related]
4. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases. Molaei A; Molaei E; Hayes AW; Karimi G Cell Cycle; 2023 Jul; 22(13):1654-1674. PubMed ID: 37365840 [TBL] [Abstract][Full Text] [Related]
5. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds. Wasan KM; Risovic V; Yuen VG; McNeill JH J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900 [TBL] [Abstract][Full Text] [Related]
7. Novel insights of dietary polyphenols and obesity. Wang S; Moustaid-Moussa N; Chen L; Mo H; Shastri A; Su R; Bapat P; Kwun I; Shen CL J Nutr Biochem; 2014 Jan; 25(1):1-18. PubMed ID: 24314860 [TBL] [Abstract][Full Text] [Related]
8. A systematic review of p53 regulation of oxidative stress in skeletal muscle. Beyfuss K; Hood DA Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131 [TBL] [Abstract][Full Text] [Related]
9. Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats. Singh J; Kakkar P Food Chem Toxicol; 2013 Dec; 62():722-31. PubMed ID: 24140466 [TBL] [Abstract][Full Text] [Related]
10. Effect of vanadium on insulin sensitivity and appetite. Wang J; Yuen VG; McNeill JH Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143 [TBL] [Abstract][Full Text] [Related]
11. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis. Mehdi MZ; Srivastava AK Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077 [TBL] [Abstract][Full Text] [Related]
12. The ménage à trois of autophagy, lipid droplets and liver disease. Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741 [TBL] [Abstract][Full Text] [Related]
13. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and medical importance of vanadium compounds. Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D Acta Biochim Pol; 2012; 59(2):195-200. PubMed ID: 22693688 [TBL] [Abstract][Full Text] [Related]
15. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Croze ML; Soulage CO Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390 [TBL] [Abstract][Full Text] [Related]
16. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724 [TBL] [Abstract][Full Text] [Related]